Petmed Express Inc PETS
We take great care to ensure that the data presented and summarized in this overview for PETMED EXPRESS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PETS
View all-
Jim Simons Renaissance Technologies LLC | New York, Ny1.27MShares$2.54 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA964KShares$1.93 Million0.0% of portfolio
-
Hotchkis & Wiley Capital Management LLC Los Angeles, CA788KShares$1.58 Million0.01% of portfolio
-
Black Rock Inc. New York, NY556KShares$1.11 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA482KShares$964,7720.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX482KShares$963,0340.0% of portfolio
-
Oaktop Capital Management Ii, L.P. Chatham, NJ436KShares$871,6880.15% of portfolio
-
Geode Capital Management, LLC Boston, MA203KShares$406,9260.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il182KShares$363,7580.0% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA175KShares$350,4660.0% of portfolio
Latest Institutional Activity in PETS
Top Purchases
Top Sells
About PETS
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Insider Transactions at PETS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 30
2025
|
Gian Fulgoni Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,846
+17.61%
|
-
|
|
Oct 30
2025
|
Peter Batushansky Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,846
+48.2%
|
-
|
|
Oct 30
2025
|
Leah Solivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,846
+44.46%
|
-
|
|
Oct 30
2025
|
Justin L. Mennen Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,846
+44.21%
|
-
|
|
Oct 30
2025
|
James La Camp Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,866
+50.0%
|
-
|
|
Oct 30
2025
|
Douglas Krulik CAO and Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+22.22%
|
-
|
|
Sep 09
2025
|
Douglas Krulik CAO and Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+16.67%
|
-
|
|
Aug 13
2025
|
Silvercape Investments LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
101,000
+3.77%
|
$303,000
$3.17 P/Share
|
|
Aug 01
2025
|
Silvercape Investments LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
118,200
+4.55%
|
$354,600
$3.21 P/Share
|
|
Jul 21
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,000
+0.96%
|
$75,000
$3.5 P/Share
|
|
Jul 18
2025
|
Silvercape Investments LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
17,565
+0.74%
|
$52,695
$3.23 P/Share
|
|
Jul 17
2025
|
Silvercape Investments LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
31,701
+1.34%
|
$95,103
$3.15 P/Share
|
|
Jul 02
2025
|
Silvercape Investments LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,817
+0.12%
|
$8,451
$3.22 P/Share
|
|
Jul 01
2025
|
Silvercape Investments LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
694
+0.03%
|
$2,082
$3.21 P/Share
|
|
Jun 03
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,000
+0.97%
|
$75,000
$3.94 P/Share
|
|
May 21
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,000
+0.98%
|
$75,000
$3.86 P/Share
|
|
May 20
2025
|
Silvercape Investments LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
7,401
+0.32%
|
$22,203
$3.95 P/Share
|
|
Apr 30
2025
|
Sandra Yvette Campos CEO & President |
SELL
Open market or private sale
|
Direct |
60,463
-4.74%
|
$181,389
$3.32 P/Share
|
|
Apr 09
2025
|
Peter Batushansky Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,527
+50.0%
|
-
|
|
Mar 18
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+3.85%
|
$400,000
$4.08 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 358K shares |
|---|---|
| Open market or private purchase | 704K shares |
| Open market or private sale | 60.5K shares |
|---|